Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cingal vs Cortisone in Shoulder Osteoarthritis
NCT05408065Recruiting
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Nov 2022
- Primary completion
- Sep 2026
- Modality
- Injectable Hydrogels, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of triamcinolone hexacetonide + hyaluronic acid in osteoarthritis (OA) (2 arms), sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Visual Analogue Scale Score at 3 months. Started Nov 2022; status: recruiting.
02
Drugs
triamcinolone hexacetonide + hyaluronic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05408065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05408065.